Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alpha Omega Services (AOS) is a specialized medical service and manufacturing company that supports the radiation oncology and nuclear medicine sectors. Founded in 1982, the company is a global leader in the management of radioactive materials, particularly the installation and exchange of Cobalt-60 sources for Gamma Knife stereotactic radiosurgery systems. AOS also designs and manufactures high-performance radiation shielding and Type B transport containers required for the safe movement of medical isotopes. Their services are essential for hospitals and clinics performing high-precision radiotherapy for brain tumors and other neurological conditions. The company operates out of its headquarters in Bellflower, California, and serves a global client base including major medical device manufacturers and healthcare institutions. By ensuring the safe and efficient handling of hazardous radioactive materials, AOS plays a critical role in the operational continuity of advanced cancer treatment facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alpha Omega Services.